Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

BlackRock Total Factor Fund to be liquidated

https://www.sec.gov/Archives/edgar/data/844779/000119312523155494/d496198d497.htm

497 1 d496198d497.htm BLACKROCK TOTAL FACTOR FUND
BLACKROCK FUNDSSM

BlackRock Total Factor Fund

Supplement dated May 26, 2023 to the

Summary Prospectuses, Prospectuses and Statement of Additional Information of the Fund,

each dated November 28, 2022

On May 23, 2023, the Board of Trustees of BlackRock FundsSM (the “Trust”), on behalf of its series, BlackRock Total Factor Fund (the “Fund”), approved a proposal to close the Fund to new and subsequent investments and thereafter to liquidate the Fund. Accordingly, effective 4:00 p.m. (Eastern time) on September 22, 2023, the Fund will no longer accept orders from new investors or existing shareholders to purchase Fund shares. On or about September 29, 2023 (the “Liquidation Date”), all of the assets of the Fund will have been liquidated completely, the shares of any shareholders holding shares on the Liquidation Date will be redeemed at the net asset value per share and the Fund will then be terminated as a series of the Trust. Shareholders may redeem their Fund shares or exchange their shares into shares of another mutual fund advised by BlackRock Advisors, LLC or its affiliates at any time prior to the Liquidation Date. In preparation for the liquidation, the Fund may deviate from its investment objective and principal investment strategies.

Shareholders should consult their personal tax advisers concerning their tax situation and the impact of the liquidation and/or exchanging to a different fund on their tax situation.

Shareholders should retain this Supplement for future reference.

PR2SAI-TFF-0523SUP
Sign In or Register to comment.